Allworth Financial’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Allworth Financial’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66	Closed	-$7.08K	–	3424
2023 Q1	$7.08K	Buy	+66	New	+$7.6K	﹤0.01%	1913

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Allworth Financial's RXDX Position: Q2 2023 in Review

Allworth Financial sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 66 shares — an estimated $7.08K sold.

Allworth Financial first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $7.08K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Allworth Financial reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Allworth Financial sold 66 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $7.08K.
Allworth Financial first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Allworth Financial's Prometheus Biosciences, Inc. Common Stock position peaked at $7.08K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Allworth Financial's 13F filing for Q2 2023, filed 18 Jul 2023.